CHAIN Welcomes New Starters
CHAIN has hired two new world class scientific team members to expand its role in Clostridia Technology and cement its position in world-leading synthetic biology.
Dr Janina Koelschbach comes to CHAIN from the Biofilm Centre at the University of Duisburg-Essen, Germany, where she set up a laboratory for anaerobic research. She earned her PhD in Microbial Biochemistry from the Technical University of Munich working in the field of anaerobic microbial degradation of polycyclic aromatic hydrocarbons. Her research involved synthetic biology and microbial engineering of challenging and unconventional microorganisms.
Janina will bring with her a wealth of knowledge and experience, and will undertake the role of scientific project lead on the Polyunsaturated Fatty Acids (PUFA) project at the Synthetic Biology Research Centre in Nottingham. Fatty acids, like Omega 3, are essential for growth but are currently sourced from dwindling fish stocks. The aim of the project is to explore a potentially sustainable, environmentally-friendly route to fatty acids like Omega 3 through fermentation.
In support of CHAIN’s commercial agreement with the University of Nottingham to promote and commercialise the University’s pMTL80000 series of modular plasmids, we have brought Dr Daniela Heeg on board as Technical Product Manager to oversee development, management and global distribution of the modular plasmid series, as well as providing expert customer technical support. Daniela performed her PhD working on clostridial spores as part of the Marie Curie Network CLOSTNET under Prof Nigel Minton at the University of Nottingham. There, she gained valuable personal knowledge and experience working with clostridia and the modular plasmids she is currently overseeing.
Daniela has a history of clostridia research. She continued her work as a postdoctoral researcher in Prof Minton’s Clostridium Research Group, working with the pathogen Clostridium difficile in collaboration with the Biomedical Research Unit of Nottingham University’s Queen’s Medical Centre. Daniela’s background in Clostridium and spore research adds significant weight to CHAIN’s position as leaders in the field of Clostridia.